Annual FCF:
-$159.70M-$50.59M(-46.36%)Summary
- As of today, CLDX annual free cash flow is -$159.70 million, with the most recent change of -$50.59 million (-46.36%) on December 31, 2024.
- During the last 3 years, CLDX annual free cash flow has fallen by -$97.54 million (-156.92%).
- CLDX annual free cash flow is now -1003.48% below its all-time high of $17.68 million, reached on December 31, 2006.
Performance
CLDX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$44.73M+$9.90M(+18.13%)Summary
- As of today, CLDX quarterly free cash flow is -$44.73 million, with the most recent change of +$9.90 million (+18.13%) on June 30, 2025.
- Over the past year, CLDX quarterly free cash flow has dropped by -$15.13 million (-51.12%).
- CLDX quarterly free cash flow is now -222.89% below its all-time high of $36.40 million, reached on March 31, 2006.
Performance
CLDX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$188.48M-$15.13M(-8.73%)Summary
- As of today, CLDX TTM free cash flow is -$188.48 million, with the most recent change of -$15.13 million (-8.73%) on June 30, 2025.
- Over the past year, CLDX TTM free cash flow has dropped by -$65.55 million (-53.32%).
- CLDX TTM free cash flow is now -677.91% below its all-time high of $32.61 million, reached on March 31, 2006.
Performance
CLDX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CLDX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -46.4% | -51.1% | -53.3% |
| 3Y3 Years | -156.9% | -95.2% | -137.2% |
| 5Y5 Years | -238.7% | -268.7% | -295.9% |
CLDX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -156.9% | at low | -133.6% | +19.9% | -92.5% | at low |
| 5Y | 5-Year | -280.6% | at low | -719.6% | +19.9% | -349.2% | at low |
| All-Time | All-Time | -1003.5% | at low | -222.9% | +19.9% | -677.9% | at low |
CLDX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.73M(+18.1%) | -$188.48M(-8.7%) |
| Mar 2025 | - | -$54.64M(-64.4%) | -$173.35M(-8.6%) |
| Dec 2024 | -$159.70M(-46.4%) | -$33.23M(+40.5%) | -$159.70M(-0.0%) |
| Sep 2024 | - | -$55.88M(-88.8%) | -$159.66M(-29.9%) |
| Jun 2024 | - | -$29.60M(+27.8%) | -$122.93M(-1.6%) |
| Mar 2024 | - | -$40.98M(-23.4%) | -$120.94M(-10.8%) |
| Dec 2023 | -$109.11M(-3.4%) | -$33.20M(-73.4%) | -$109.11M(-11.4%) |
| Sep 2023 | - | -$19.15M(+30.6%) | -$97.91M(+14.3%) |
| Jun 2023 | - | -$27.61M(+5.3%) | -$114.29M(-4.3%) |
| Mar 2023 | - | -$29.15M(-32.5%) | -$109.61M(-3.8%) |
| Dec 2022 | -$105.56M(-69.8%) | -$22.00M(+38.1%) | -$105.56M(-7.2%) |
| Sep 2022 | - | -$35.54M(-55.1%) | -$98.44M(-23.9%) |
| Jun 2022 | - | -$22.92M(+8.7%) | -$79.46M(-15.8%) |
| Mar 2022 | - | -$25.11M(-68.8%) | -$68.62M(-10.4%) |
| Dec 2021 | -$62.16M(-48.2%) | -$14.88M(+10.1%) | -$62.16M(-17.9%) |
| Sep 2021 | - | -$16.56M(-37.1%) | -$52.74M(-9.4%) |
| Jun 2021 | - | -$12.07M(+35.3%) | -$48.20M(+0.1%) |
| Mar 2021 | - | -$18.65M(-241.7%) | -$48.26M(-15.0%) |
| Dec 2020 | -$41.96M(+11.0%) | -$5.46M(+54.6%) | -$41.96M(+11.9%) |
| Sep 2020 | - | -$12.02M(+0.9%) | -$47.60M(-1.6%) |
| Jun 2020 | - | -$12.13M(+1.7%) | -$46.86M(-1.7%) |
| Mar 2020 | - | -$12.35M(-11.2%) | -$46.07M(+2.3%) |
| Dec 2019 | -$47.15M(+38.0%) | -$11.11M(+1.6%) | -$47.15M(+8.7%) |
| Sep 2019 | - | -$11.28M(+0.5%) | -$51.63M(+5.8%) |
| Jun 2019 | - | -$11.34M(+15.5%) | -$54.80M(+10.4%) |
| Mar 2019 | - | -$13.42M(+13.9%) | -$61.19M(+19.5%) |
| Dec 2018 | -$76.05M(+25.2%) | -$15.59M(-7.9%) | -$76.05M(+5.1%) |
| Sep 2018 | - | -$14.45M(+18.5%) | -$80.17M(+11.3%) |
| Jun 2018 | - | -$17.73M(+37.3%) | -$90.36M(+4.2%) |
| Mar 2018 | - | -$28.28M(-43.5%) | -$94.36M(+7.2%) |
| Dec 2017 | -$101.72M(+12.1%) | -$19.71M(+20.0%) | -$101.72M(+1.2%) |
| Sep 2017 | - | -$24.64M(-13.4%) | -$103.00M(+0.1%) |
| Jun 2017 | - | -$21.73M(+39.0%) | -$103.11M(+11.1%) |
| Mar 2017 | - | -$35.64M(-69.8%) | -$115.98M(-0.2%) |
| Dec 2016 | -$115.79M(-11.6%) | -$20.99M(+15.2%) | -$115.79M(-6.3%) |
| Sep 2016 | - | -$24.76M(+28.4%) | -$108.95M(+3.9%) |
| Jun 2016 | - | -$34.60M(+2.4%) | -$113.34M(-7.9%) |
| Mar 2016 | - | -$35.44M(-150.4%) | -$105.06M(-1.2%) |
| Dec 2015 | -$103.76M(-0.3%) | -$14.15M(+51.5%) | -$103.76M(+7.3%) |
| Sep 2015 | - | -$29.15M(-10.8%) | -$111.99M(-1.7%) |
| Jun 2015 | - | -$26.31M(+23.0%) | -$110.10M(-4.3%) |
| Mar 2015 | - | -$34.15M(-52.6%) | -$105.55M(-2.0%) |
| Dec 2014 | -$103.47M(-43.9%) | -$22.38M(+17.9%) | -$103.47M(-5.2%) |
| Sep 2014 | - | -$27.26M(-25.3%) | -$98.36M(-9.9%) |
| Jun 2014 | - | -$21.75M(+32.2%) | -$89.54M(-3.4%) |
| Mar 2014 | - | -$32.07M(-85.6%) | -$86.60M(-20.5%) |
| Dec 2013 | -$71.89M(-43.5%) | -$17.27M(+6.3%) | -$71.89M(-5.6%) |
| Sep 2013 | - | -$18.44M(+2.0%) | -$68.05M(-12.2%) |
| Jun 2013 | - | -$18.81M(-8.4%) | -$60.63M(-12.6%) |
| Mar 2013 | - | -$17.36M(-29.2%) | -$53.85M(-7.5%) |
| Dec 2012 | -$50.09M(-38.5%) | -$13.44M(-22.0%) | -$50.09M(-8.6%) |
| Sep 2012 | - | -$11.02M(+8.5%) | -$46.13M(-6.5%) |
| Jun 2012 | - | -$12.04M(+11.4%) | -$43.29M(-6.4%) |
| Mar 2012 | - | -$13.60M(-43.5%) | -$40.70M(-12.5%) |
| Dec 2011 | -$36.17M(-11.4%) | -$9.48M(-15.8%) | -$36.17M(-9.1%) |
| Sep 2011 | - | -$8.18M(+13.4%) | -$33.14M(+0.3%) |
| Jun 2011 | - | -$9.45M(-4.2%) | -$33.24M(+2.8%) |
| Mar 2011 | - | -$9.07M(-40.5%) | -$34.21M(-5.4%) |
| Dec 2010 | -$32.47M(-6.8%) | -$6.45M(+22.0%) | -$32.47M(+12.1%) |
| Sep 2010 | - | -$8.28M(+20.6%) | -$36.95M(-7.7%) |
| Jun 2010 | - | -$10.42M(-42.3%) | -$34.29M(-7.1%) |
| Mar 2010 | - | -$7.32M(+33.0%) | -$32.03M(-5.4%) |
| Dec 2009 | -$30.40M(-279.1%) | -$10.93M(-94.5%) | -$30.40M(-67.0%) |
| Sep 2009 | - | -$5.62M(+31.1%) | -$18.20M(+18.9%) |
| Jun 2009 | - | -$8.16M(-43.3%) | -$22.44M(-243.8%) |
| Mar 2009 | - | -$5.69M(-548.7%) | $15.61M(-8.1%) |
| Dec 2008 | $16.98M(+169.9%) | $1.27M(+112.9%) | $16.98M(+721.5%) |
| Sep 2008 | - | -$9.86M(-133.0%) | -$2.73M(-144.1%) |
| Jun 2008 | - | $29.89M(+792.0%) | $6.19M(+123.8%) |
| Mar 2008 | - | -$4.32M(+76.6%) | -$26.07M(-7.4%) |
| Dec 2007 | -$24.28M | -$18.44M(-1874.2%) | -$24.28M(-109.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$934.00K(+60.7%) | -$11.59M(+33.4%) |
| Jun 2007 | - | -$2.38M(+5.9%) | -$17.39M(+18.2%) |
| Mar 2007 | - | -$2.53M(+56.0%) | -$21.25M(-220.2%) |
| Dec 2006 | $17.68M(+315.8%) | -$5.75M(+14.7%) | $17.68M(-28.4%) |
| Sep 2006 | - | -$6.74M(-8.1%) | $24.67M(-7.3%) |
| Jun 2006 | - | -$6.24M(-117.1%) | $26.62M(-18.4%) |
| Mar 2006 | - | $36.40M(+2813.8%) | $32.61M(+498.1%) |
| Dec 2005 | -$8.19M(+41.5%) | $1.25M(+126.1%) | -$8.19M(+45.6%) |
| Sep 2005 | - | -$4.79M(-1859.2%) | -$15.07M(-4.3%) |
| Jun 2005 | - | -$244.60K(+94.4%) | -$14.45M(+9.7%) |
| Mar 2005 | - | -$4.40M(+21.8%) | -$16.00M(-14.3%) |
| Dec 2004 | -$14.00M(-17.2%) | -$5.63M(-35.0%) | -$14.00M(-21.2%) |
| Sep 2004 | - | -$4.17M(-131.4%) | -$11.55M(-13.8%) |
| Jun 2004 | - | -$1.80M(+25.0%) | -$10.15M(+8.6%) |
| Mar 2004 | - | -$2.40M(+24.6%) | -$11.11M(+7.0%) |
| Dec 2003 | -$11.95M(+31.7%) | -$3.18M(-15.0%) | -$11.95M(-20.5%) |
| Sep 2003 | - | -$2.77M(-0.2%) | -$9.92M(+20.4%) |
| Jun 2003 | - | -$2.76M(+14.7%) | -$12.47M(+17.4%) |
| Mar 2003 | - | -$3.24M(-181.5%) | -$15.09M(+13.8%) |
| Dec 2002 | -$17.50M(+19.0%) | -$1.15M(+78.4%) | -$17.50M(+20.5%) |
| Sep 2002 | - | -$5.32M(+1.3%) | -$22.01M(+3.1%) |
| Jun 2002 | - | -$5.39M(+4.6%) | -$22.72M(-3.8%) |
| Mar 2002 | - | -$5.65M(+0.2%) | -$21.89M(-1.3%) |
| Dec 2001 | -$21.60M(-341.6%) | -$5.66M(+6.2%) | -$21.60M(-32.2%) |
| Sep 2001 | - | -$6.03M(-32.2%) | -$16.34M(-26.2%) |
| Jun 2001 | - | -$4.56M(+14.9%) | -$12.95M(-14.3%) |
| Mar 2001 | - | -$5.36M(-1269.2%) | -$11.33M(-131.6%) |
| Dec 2000 | -$4.89M(+48.9%) | -$391.40K(+85.2%) | -$4.89M(+17.0%) |
| Sep 2000 | - | -$2.64M(+10.3%) | -$5.90M(-4.3%) |
| Jun 2000 | - | -$2.94M(-372.7%) | -$5.65M(-7.0%) |
| Mar 2000 | - | $1.08M(+177.3%) | -$5.29M(+42.7%) |
| Dec 1999 | -$9.57M(+0.0%) | -$1.40M(+41.7%) | -$9.23M(-2.4%) |
| Sep 1999 | - | -$2.39M(+6.9%) | -$9.01M(+14.1%) |
| Jun 1999 | - | -$2.57M(+10.2%) | -$10.48M(-3.6%) |
| Mar 1999 | - | -$2.86M(-143.7%) | -$10.12M(-10.7%) |
| Dec 1998 | -$9.57M(-17.4%) | -$1.18M(+69.6%) | -$9.15M(+9.2%) |
| Sep 1998 | - | -$3.87M(-75.1%) | -$10.07M(-22.8%) |
| Jun 1998 | - | -$2.21M(-17.0%) | -$8.20M(-8.0%) |
| Mar 1998 | - | -$1.89M(+10.0%) | -$7.59M(+2.7%) |
| Dec 1997 | -$8.15M(+21.0%) | -$2.10M(-5.0%) | -$7.80M(+4.9%) |
| Sep 1997 | - | -$2.00M(-25.0%) | -$8.20M(+2.4%) |
| Jun 1997 | - | -$1.60M(+23.8%) | -$8.40M(+3.4%) |
| Mar 1997 | - | -$2.10M(+16.0%) | -$8.70M(+15.5%) |
| Dec 1996 | -$10.32M(-5.9%) | -$2.50M(-13.6%) | -$10.30M(-51.5%) |
| Sep 1996 | - | -$2.20M(-15.8%) | -$6.80M(+20.9%) |
| Jun 1996 | - | -$1.90M(+48.6%) | -$8.60M(+5.5%) |
| Mar 1996 | - | -$3.70M(-470.0%) | -$9.10M(-7.1%) |
| Dec 1995 | -$9.74M(+6.2%) | $1.00M(+125.0%) | -$8.50M(+30.3%) |
| Sep 1995 | - | -$4.00M(-66.7%) | -$12.20M(-18.4%) |
| Jun 1995 | - | -$2.40M(+22.6%) | -$10.30M(+4.6%) |
| Mar 1995 | - | -$3.10M(-14.8%) | -$10.80M(-9.1%) |
| Dec 1994 | -$10.38M(-73.1%) | -$2.70M(-28.6%) | -$9.90M(-20.7%) |
| Sep 1994 | - | -$2.10M(+27.6%) | -$8.20M(-9.3%) |
| Jun 1994 | - | -$2.90M(-31.8%) | -$7.50M(-17.2%) |
| Mar 1994 | - | -$2.20M(-120.0%) | -$6.40M(-6.7%) |
| Dec 1993 | -$6.00M(-36.4%) | -$1.00M(+28.6%) | -$6.00M(-20.0%) |
| Sep 1993 | - | -$1.40M(+22.2%) | -$5.00M(+3.8%) |
| Jun 1993 | - | -$1.80M(0.0%) | -$5.20M(-8.3%) |
| Mar 1993 | - | -$1.80M(-12.5%) | -$4.80M(+5.9%) |
| Dec 1992 | -$4.40M(+2.2%) | - | - |
| Oct 1992 | - | -$1.60M(-14.3%) | -$5.10M(0.0%) |
| Jul 1992 | - | -$1.40M(+6.7%) | -$5.10M(-13.3%) |
| Apr 1992 | - | -$1.50M(-150.0%) | -$4.50M(-40.6%) |
| Apr 1992 | -$4.50M(-32.4%) | - | - |
| Jan 1992 | - | -$600.00K(+62.5%) | -$3.20M(+15.8%) |
| Oct 1991 | - | -$1.60M(-100.0%) | -$3.80M(0.0%) |
| Jul 1991 | - | -$800.00K(-300.0%) | -$3.80M(-11.8%) |
| Apr 1991 | -$3.40M(-142.9%) | -$200.00K(+83.3%) | -$3.40M(-6.3%) |
| Jan 1991 | - | -$1.20M(+25.0%) | -$3.20M(-60.0%) |
| Oct 1990 | - | -$1.60M(-300.0%) | -$2.00M(-400.0%) |
| Jul 1990 | - | -$400.00K | -$400.00K |
| Apr 1990 | -$1.40M | - | - |
FAQ
- What is Celldex Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Celldex Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Celldex Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of CLDX is -$159.70M
What is the all-time high annual free cash flow for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual free cash flow is $17.68M
What is Celldex Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, CLDX annual free cash flow has changed by -$50.59M (-46.36%)
What is Celldex Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of CLDX is -$44.73M
What is the all-time high quarterly free cash flow for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly free cash flow is $36.40M
What is Celldex Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, CLDX quarterly free cash flow has changed by -$15.13M (-51.12%)
What is Celldex Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of CLDX is -$188.48M
What is the all-time high TTM free cash flow for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high TTM free cash flow is $32.61M
What is Celldex Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, CLDX TTM free cash flow has changed by -$65.55M (-53.32%)